🇺🇸 Hydrochlorothiazide (HCT) in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Gastrointestinal Haemorrhage — 2 reports (16.67%)
  2. Pruritus — 2 reports (16.67%)
  3. Anaemia — 1 report (8.33%)
  4. Anaphylactic Shock — 1 report (8.33%)
  5. Angioedema — 1 report (8.33%)
  6. Blood Urine Present — 1 report (8.33%)
  7. Bone Marrow Depression — 1 report (8.33%)
  8. Bronchitis Chronic — 1 report (8.33%)
  9. Cardiac Failure — 1 report (8.33%)
  10. Cerebrovascular Accident — 1 report (8.33%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Hydrochlorothiazide (HCT) approved in United States?

Hydrochlorothiazide (HCT) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Hydrochlorothiazide (HCT) in United States?

Takeda is the originator. The local marketing authorisation holder may differ — check the official source linked above.